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Iron (Fe) is an essential cofactor for a wide range of
cellular processes. We have previously demon-
strated in yeast that Cth2 is expressed during Fe
deficiency and promotes degradation of a battery
of mRNAs leading to reprogramming of Fe-depen-
dent metabolism and Fe storage. We report here
that the Cth2-homologous protein Cth1 is transiently
expressed during Fe deprivation and participates in
the response to Fe deficiency through the degrada-
tion of mRNAs primarily involved in mitochondrially
localized activities including respiration and amino
acid biosynthesis. In parallel, wild-type cells, but
not cth1Dcth2D cells, accumulate mRNAs encoding
proteins that function in glucose import and storage
and store high levels of glycogen. In addition, Fe de-
ficiency leads to phosphorylation of Snf1, an AMP-
activated protein kinase family member required for
the cellular response to glucose starvation. These
studies demonstrate a metabolic reprogramming as
a consequence of Fe starvation that is dependent
on the coordinated activities of two mRNA-binding
proteins.
INTRODUCTION
The ability of iron (Fe) to engage in redox reactions makes it
a widely utilized cofactor in many central biochemical processes
including oxygen delivery and storage, mitochondrial oxidative
phosphorylation, DNA replication and repair, lipid metabolism,
and chromatinmodification. Abnormal Fe accumulation, in either
excessiveor insufficient levels, underlies several humandiseases
including hereditary hemochromatosis, Friedreich’s ataxia, acer-
uloplasminemia, and Fe-deficiency anemia (Dunn et al., 2007;
Hentze et al., 2004; Rouault, 2006). Indeed, Fe deficiency re-
presents the most common nutritional deficiency, estimated to
affect more than two billion people worldwide (Baynes and
Bothwell, 1990).
Given the importance of Fe in health and disease, Fe homeo-
stasis has been under intensive investigation aimed at elucidat-
ing the mechanisms of Fe acquisition, distribution, and regula-
tion (Escolar et al., 1999; Hentze et al., 2004; Kaplan et al.,
2006; Rouault, 2006; Dunn et al., 2007; Philpott and Protchenko,2008). One regulatory mechanism for Fe homeostasis in mam-
mals involves the iron-regulatory proteins IRP1 and IRP2, which
posttranscriptionally modulate the expression of specific
mRNAs in response to intracellular Fe (Hentze et al., 2004;
Rouault, 2006). When cellular Fe is low, IRP1 and IRP2 bind to
stem-loop structures, known as iron-responsive elements
(IREs), within the 50 untranslated region (50UTR) of transcripts in-
cluding those encoding the iron storage protein ferritin, mito-
chondrial aconitase, the heme-biosynthetic enzyme eALAS,
and the Fe efflux transporter ferroportin, thereby inhibiting their
translation. Concurrently, IRP1 and IRP2 also bind IRE se-
quences within the 30UTR of the transferrin receptor mRNA,
stabilizing the transcript and thus increasing its translational effi-
ciency. As a consequence, there is a decrease in sequestration
of Fe by ferritin and an increase in the capacity to mobilize trans-
ferrin-bound Fe. Once Fe levels are adequate, IRP1 acquires
a [4Fe-4S] cluster, interconverting to a cytoplasmic aconitase,
and IRP2 is degraded (Hentze et al., 2004; Rouault, 2006). A
posttranscriptional mechanism that controls cellular Fe homeo-
stasis has also been described in bacteria. During Fe starvation,
a small noncoding RNA in Escherichia coli, RyhB, is synthesized
and promotes the degradation of mRNAs encoding proteins
involved in Fe homeostasis, Fe-dependent metabolism, and Fe
storage. Once Fe levels are adequate, expression of RyhB
ceases due to its transcriptional repression by the ferric uptake
regulator, Fur (reviewed in Masse´ et al., 2007).
Previous studies have demonstrated that under Fe-limiting
conditions, Saccharomyces cerevisiae utilizes two Fe-respon-
sive transcription factors, Aft1 and Aft2, to activate expression
of genes collectively known as the Fe regulon (Blaiseau et al.,
2001; Rutherford et al., 2001, 2003; Shakoury-Elizeh et al.,
2004; Courel et al., 2005). Additional mechanisms of Fe-in-
duced gene transcription occur in an Aft1/2-independent man-
ner (Shakoury-Elizeh et al., 2004; Li et al., 2008). Genes in
the Fe regulon encode proteins involved in Fe uptake, redistri-
bution of intracellular Fe stores, Fe-S biogenesis, and heme
utilization.
Concomitant with transcription of the Fe regulon under con-
ditions of Fe deficiency, the steady-state levels of mRNAs
encoding enzymes involved in many Fe-dependent metabolic
processes including the tricarboxylic acid (TCA) cycle, mito-
chondrial respiration, heme biosynthesis, and fatty acid synthe-
sis, as well as that coding for the Ccc1 Fe-storage protein, are
markedly reduced (Lesuisse et al., 2003; Shakoury-Elizeh
et al., 2004; Puig et al., 2005). A member of the Fe regulon,
Cth2, belongs to a family of mRNA-binding proteins conservedCell Metabolism 7, 555–564, June 2008 ª2008 Elsevier Inc. 555
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Metabolic Adaptation to Iron LimitationFigure 1. Overexpression of CTH1 Partially
Rescues cth2D Phenotypes
(A) Representation of the Cth1 and Cth2 proteins.
Themutation within the tandem zinc finger (TZF) of
Cth1 is indicated.
(B) Overexpression of CTH1 partially suppresses
the growth defect of cth1Dcth2D cells on iron
(Fe)-depleted medium. BY4741 cells transformed
with pRS416 (wild-type) and cth1Dcth2D cells
transformed with pRS416 (vector), pRS416-
CTH2, pRS416-CTH1, or pRS416-CTH2:CTH1
were spotted on SC-Ura or SC-Ura + 750 mM
ferrozine to induce Fe-deprived conditions.
(C) Overexpression of CTH1 promotes downregu-
lation of Cth2 mRNA targets. BY4741 cells trans-
formed with pRS416 (WT) and cth1Dcth2D cells
transformed with pRS416 (vector), pRS416-
CTH1, pRS416-CTH2, or pRS416-CTH2:CTH1
were grown in medium containing either 300 mM
ferrous ammonium sulfate (FAS; Fe+) or 100 mM
bathophenanthroline disulfonate (BPS; Fe), and steady-state levels of SDH4 and CCP1 were analyzed by RNA blotting. ACT1 was used as a loading control.
(D) Cth1 and Cth2 promote downregulation of the SDH4 transcript independently of Fe levels. cth1Dcth2D cells transformed with p416TEF1, p416TEF1-CTH1, or
p416TEF1-CTH2 were grown and assayed as in (C).from yeast to humans that is characterized by the presence
of two tandem zinc fingers of the CX8CX5CX3H type (CCCH)
that constitute an mRNA-binding domain (Thompson et al.,
1996; Blackshear, 2002). Members of this family of proteins
promote the rapid degradation of select mRNA molecules by
recruiting RNA decay enzymes to AU-rich element (ARE)-con-
taining mRNAs (Lai et al., 2005; Lykke-Andersen and Wagner,
2005). Cth2 protein binds AREs within the 30UTR of many
mRNAs encoding proteins involved in Fe homeostasis and Fe-
dependent metabolic processes, thereby promotingmRNA deg-
radation (Puig et al., 2005). Consistent with a role for Cth2 in or-
chestrating genome-wide changes in metabolism in response to
Fe deficiency, cth2D cells exhibit a growth defect on low-Fe
medium. Furthermore, the growth defect of cth2D cells is exac-
erbated by a mutation in the CTH1 gene, encoding a putative
homolog of Cth2, whose function has not been previously
described.
Here we demonstrate that the CTH1 gene is a direct target of
the Aft1/2 transcription factors that is activated rapidly and
transiently in response to Fe deficiency. Microarray analyses
revealed that, while Cth2 predominantly stimulates the degrada-
tion of mRNAs encoding general Fe-homeostasis and Fe-
utilizing proteins that function in metabolism, Cth1 preferentially
targets mRNAs encoding components of the mitochondrial oxi-
dative phosphorylation machinery and other known or predicted
mitochondrial functions. Moreover, we demonstrate that Cth1-
and Cth2-stimulated mRNA decay results in the elevated
expression of genes that are involved in the transport, metabo-
lism, and storage of glucose. Consistent with this regulation,
Fe starvation results in elevated glycogen levels and activation
of Snf1 protein kinase, a central regulator of cellular carbon
metabolism. Taken together, the S. cerevisiae Cth1 and Cth2
mRNA-binding proteins play critical roles in targeting specific
functional classes of mRNAs for degradation in response to Fe
deficiency. Moreover, the coordinated activities of these two
proteins impart changes in cellular metabolism consistent with
a shift away from oxidative phosphorylation and toward carbo-
hydrate utilization.556 Cell Metabolism 7, 555–564, June 2008 ª2008 Elsevier Inc.RESULTS
CTH1 Function in Response to Iron Deficiency
The yeast genome harbors a gene encoding a protein structurally
related to Cth2, Cth1, which shares an overall 46% identity and
56%similarity withCth2, aswell as 79% identitywithin the tandem
zinc finger (TZF) domains (Figure 1A). The TZF region of Cth2 and
other TZF protein family members is essential for binding to ARE
sequences within the 30UTR of their target mRNAs (Lai et al.,
2000;Hudsonetal., 2004;Puigetal., 2005).Wedemonstratedpre-
viously that cth2D cells growpoorly on Fe-limitedmedium and ex-
hibit defects in the degradation of a specific set of ARE-containing
mRNAs (Puig et al., 2005). Furthermore, deletion of theCTH1 gene
exacerbates the growth and mRNA degradation defects of cth2D
cells under Fe-limiting conditions (Puig et al., 2005). To evaluate
the function of Cth1 during Fe deficiency, Cth1was expressed un-
der conditionsofFedeficiencyby fusing theCTH2promoter region
to the CTH1 coding sequence (CTH2:CTH1). The CTH2:CTH1
plasmid conferred an Fe-regulated pattern of expression to
CTH1 similar to CTH2 mRNA, as ascertained by RNA blotting
experiments (data not shown). Cells (cth1Dcth2D) harboring the
empty vector or containing the CTH1, CTH2, orCTH2:CTH1 plas-
midwereevaluated for cell growthunder conditions of Fe limitation
and for steady-state levels of mRNAs known to be degraded in
a Cth2-dependent manner. As shown in Figure 1B, the growth de-
fect of cth1Dcth2D cells on Fe-chelatedmediumwas only partially
suppressedbynativeCTH1 expression levels butwasmore signif-
icantly rescued in cells harboring the CTH2 or CTH2:CTH1 plas-
mid. The steady-state levels of two Cth2 target mRNAs, SDH4
and CCP1, were examined by RNA blotting. Both SDH4 and
CCP1 encode mitochondrial Fe-dependent enzymes—a subunit
of the succinate dehydrogenase complex and cytochrome c per-
oxidase, respectively. As observed previously (Puig et al., 2005)
and as shown in Figure 1C, both CCP1 and SDH4 mRNA levels
were greatly reduced as a consequence of Fe limitation in wild-
type cells, but not in cth1Dcth2D cells carrying an empty vector.
In contrast, there was a significant decrease in both CCP1 and
SDH4 mRNA steady-state levels in cth1Dcth2D cells expressing
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Metabolic Adaptation to Iron LimitationFigure 2. CTH1 Is Rapidly and Transiently Activated by Aft1 and Aft2 during Iron-Limiting Conditions
(A) Representation of the promoter region of CTH1, the two putative Aft1/2-binding sites, and the CTH1:lacZ fusion used for b-galactosidase assays.
(B) Aft1 occupancy of theCTH1 promoter was tested by chromatin immunoprecipitation (ChIP) from cells grown in medium containing either 300 mMFAS (Fe+) or
100 mM BPS (Fe) to exponential phase. ChIP was performed as described in Experimental Procedures. CMD1 was used as a negative control, and FET3 and
CTH2 were used as positive controls.
(C) Aft1 and Aft2 transcription factors are required for CTH1:lacZ reporter activation upon Fe deficiency. Wild-type, aft1D, and aft1Daft2D cells expressing
aCTH1:lacZ fusion were grown under Fe+ or Fe conditions, and b-galactosidase activity was assayed. Results from four independent experiments are shown.
Error bars represent standard deviation.
(D) Mutations in the putative Aft1/2-binding sites in the CTH1 promoter region compromise Fe deficiency-dependent activation of the CTH1:lacZ reporter in
wild-type cells. Wild-type cells expressing either CTH1:lacZ or M2-CTH1:lacZ fusion were assayed as in (C). Error bars represent standard deviation.
(E) Expression of the FLAG-Cth1 fusion protein. For details, see Experimental Procedures.CTH2, CTH1, or CTH2:CTH1. Taken together, these results
indicate that Cth1 can promote a decrease in steady-state levels
of two Cth2 mRNA targets under Fe-deprivation conditions.
Although both Cth1 and Cth2 negatively regulate SDH4 and
CCP1mRNA levelsunderconditionsofFedeficiency, it isnot clear
whether Fedeficiency is needed for their function.Weascertained
whether Cth1 or Cth2 could promote a decrease in SDH4mRNA
levels under Fe-sufficient conditions. The CTH1 and CTH2 genes
were expressed independently in cth1Dcth2D cells using the
constitutive yeast TEF1 promoter. Cells expressing either the
TEF1:CTH1 or TEF1:CTH2 genes, but not vector alone, exhibited
decreased steady-state levels of the SDH4 transcript under Fe-
deficient or Fe-replete conditions (Figure 1D). These observations
demonstrate that both Cth1 and Cth2, when constitutively ex-
pressed, are able to promote a decrease in SDH4 steady-state
mRNA levels irrespective of Fe availability. These results suggest
that their activity is not regulated posttranslationally by Fe but
rather is regulated predominantly at the level of gene expression.
Aft1 and Aft2 Regulate CTH1 Transcription
While Cth1 contributes to growth and SDH4mRNA degradation
under conditions of Fe deficiency, previous studies have dem-onstrated that CTH2, but not CTH1, mRNA levels are elevated
in response to long-term Fe deficiency (Shakoury-Elizeh et al.,
2004; Puig et al., 2005). Visual inspection of the CTH1 promoter
region revealed two putative Aft1/2-binding sites starting at
nucleotide positions 286 (50-GCACCCAA-30) and 94 (50-
TCACCCAA-30) from the CTH1 translation initiation codon (Fig-
ure 2A). Furthermore, a genome-wide localization analysis of
transcription factors in S. cerevisiae revealed occupancy of
the CTH1 promoter by the Aft1 transcription factor (Lee et al.,
2002). To ascertain whether Aft1 directly activates CTH1, Aft1
recruitment to the CTH1 promoter was assessed by chromatin
immunoprecipitation (ChIP) experiments using a strain harbor-
ing a functional TAP-tagged AFT1 allele. While there was
a low level of Aft1-TAP occupancy on the FET3 and CTH2
promoters in cells grown under Fe-supplemented conditions,
Aft1-TAP was enriched in cells grown under Fe-starvation con-
ditions, as expected (Figure 2B). Moreover, we detected Aft1-
TAP occupancy on the CTH1 promoter under both Fe-supple-
mented and Fe-deprived conditions (Figure 2B). No Aft1-TAP
occupancy was detected on the CMD1 promoter, a gene not
responsive to Fe levels, under either condition (Figure 2B). To
ascertain whether Aft1 recruitment to the CTH1 promoterCell Metabolism 7, 555–564, June 2008 ª2008 Elsevier Inc. 557
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Metabolic Adaptation to Iron LimitationFigure 3. Cth1 Accelerates the Decay of
SDH4 mRNA
(A) Representation of the SDH4 transcript, the lo-
cation of the AU-rich elements (AREs) within its
30 untranslated region (30UTR), and the mutations
introduced in the ARE clusters (mt1 and mt2;
previously described in Puig et al. [2005]).
(B) Yeast three-hybrid assay used to monitor
in vivo interactions between Cth1 protein and the
ARE-containing fragment of the SDH4 30UTR
mRNA. L40-coat cells were cotransformed with
(1) pIIIA/MS2-1 containing the 30UTR of SDH4-
mt2, SDH4-mt1, SDH4, ACO1, or vector alone
(as a negative control) or containing the iron-re-
sponsive element (IRE) as a positive control, and
(2) pACT2 vector alone or fused to CTH1, CTH1-
C225R, or the iron-regulatory protein (IRP) as
a positive control. Cells were grown on SC-Ura-
Leu (+His) and SC-Ura-Leu-His (His) plates for
3–7 days at 30C. Positive interactions are indi-
cated in the box.
(C) Quantitation of the three-hybrid results. L40-
coat cells cotransformed with (1) pIIIA/MS2-1
alone or fused to the 30UTR of SDH4, SDH4-mt1,
or SDH4-mt2 and (2) pACT2-CTH1 were grown
on SC-Ura-Leu and assayed for b-galactosidase
activity. Cells were also cotransformed with (1) the 30UTR of SDH4 and (2) pACT2-CTH1-C225R and assayed for b-galactosidase activity. Error bars represent
standard deviation.
(D) Cth1 accelerates the rate of decay of the SDH4 mRNA. cth1Dcth2Dsdh4D cells were cotransformed with p415GAL1:SDH4 and pRS416 (vector, first row),
pRS416-CTH2:CTH1 (second row) and pRS416-CTH2:CTH1-C225R (fourth row), or p415GAL1:SDH4-mt2 and pRS416-CTH2:CTH1 (third row). Cells were
grown in medium containing galactose and 100 mM BPS. Glucose was added to stop SDH4 transcription, and RNA was analyzed by RNA blotting. SDH4 levels
were normalized to ACT1, and mRNA half-lives were determined from three independent experiments.results in transcriptional activation, the CTH1 promoter region
was fused to the coding sequence of a lacZ reporter gene (Fig-
ure 2A, top), and b-galactosidase activity was measured. As
shown in Figure 2C, the wild-type CTH1 promoter strongly in-
duced expression of the lacZ reporter gene under Fe-limitation
conditions in wild-type cells. This activity was decreased by
80% in the aft1D strain, and the remaining b-galactosidase
activity was further reduced in the aft1Daft2D strain to levels
approximating those detected under high-Fe conditions in all
three strains (Figure 2C). To ascertain the potential role of the
putative Aft1/2-binding sites within the CTH1 promoter on tran-
scriptional activation, both Aft1/2 consensus sites within the
CTH1:lacZ fusion were mutated at nucleotide residues pre-
viously demonstrated to be required for activation via Aft1/2
(Yamaguchi-Iwai et al., 1996; Puig et al., 2005) (Figure 2A, M2
mutant). The wild-type and M2 reporter genes were assayed
for b-galactosidase activity in response to Fe deprivation in
wild-type cells. As shown in Figure 2D, mutagenesis of both
Aft1/2 consensus promoter elements severely compromised
activation of the CTH1:lacZ fusion gene in response to Fe dep-
rivation. Immunoblotting experiments using cells grown under
Fe limitation demonstrate that a FLAG-Cth1 fusion protein is
detectable within 0.5 hr of the imposed Fe limitation, reaching
the highest steady-state levels of expression by 2 hr (Figure 2E).
These data demonstrate that the CTH1 promoter is transcrip-
tionally activated in response to Fe deficiency in a manner
that is dependent on the Fe-responsive transcription factors
Aft1 and Aft2. In addition, these data suggest that the expres-
sion of Cth1 occurs early and transiently in the response to Fe
limitation.558 Cell Metabolism 7, 555–564, June 2008 ª2008 Elsevier Inc.Cth1 Stimulates mRNA Turnover
The mRNA-destabilizing activity of Cth2 requires the integrity of
the two CX8CX5CX3H TZFs, which constitute critical Zn-coordi-
nating elements within the mRNA-binding domain, as well as the
integrity of AREs within the 30UTR of target mRNAs (Puig et al.,
2005). Given that Cth1 overexpression can partially rescue the
cth1Dcth2D-associated Fe-deficiency phenotypes, including
the SDH4 mRNA turnover deficit, we investigated the mecha-
nisms by which Cth1 mediates SDH4 mRNA downregulation.
We assayed the ability of Cth1 to interact with ARE-containing
mRNAs using the yeast three-hybrid method (SenGupta et al.,
1996). Wild-type and mutated DNA fragments encoding ARE-
containing RNAs from the SDH4 and ACO1 30UTRs (Figure 3A)
were fused to bacteriophage MS2 RNA (Puig et al., 2005) and
coexpressed in a reporter yeast strain with a Cth1-Gal4 transac-
tivation domain fusion protein. Interactions between Cth1 and
the fusion RNAs were monitored by growth on medium lacking
histidine (His) and by measuring reporter gene-driven b-galac-
tosidase activity. As shown in Figure 3B (right panel), cells
cotransformed with plasmids expressing the wild-type SDH4
or ACO1 30UTR RNA fragments fused to MS2 RNA and the
Cth1-Gal4 fusion protein could grow on medium lacking histi-
dine, indicative of an interaction between Cth1 protein and the
30UTR of the SDH4 and ACO1 mRNAs. This interaction was
not observed when SDH4 and ACO1mRNAs were coexpressed
with a mutant form of the Cth1-Gal4 fusion protein in which cys-
teine residue 225 within the TZF of Cth1 was replaced with an
arginine residue (C225R mutant, Figure 1A), suggesting that
the integrity of the TZFs is required for Cth1 to interact with the
mRNAs (Figure 3B). To further evaluate specific binding to
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in which one patch (mt1) or all ARE consensus sequences
(mt2) within the SDH4 30UTR mRNA were mutagenized (Fig-
ure 3A). As shown in Figure 3B, cells coexpressing the Cth1-
Gal4 fusion protein and SDH4-mt1 fusion RNA grew poorly in
the absence of histidine as compared to cells expressing wild-
type SDH4 RNA. Furthermore, mutation of all AREs within the
SDH4 30UTR (SDH4-mt2 allele) completely abrogated growth
on medium lacking histidine without altering growth on synthetic
complete medium (Figure 3B). As an independent means to as-
sess the Cth1-SDH4 ARE interaction, b-galactosidase activity of
the UAS-Gal4-LacZ reporter gene was measured (Figure 3C).
Cells coexpressing the wild-type Cth1-Gal4 protein and SDH4
RNA fusions exhibited abundant b-galactosidase activity. How-
ever, this activity was decreased by 40% in cells expressing
the SDH4-mt1 fusion RNA and by 90% in cells expressing
the SDH4-mt2 fusion RNA (Figure 3C). Very low b-galactosidase
activity was detected from cells coexpressing the wild-type
SDH4 fusion RNA with the Cth1 TZF mutant (Cth1 C225R-
Gal4) fusion protein. These results strongly suggest that, like
Cth2 (Puig et al., 2005), Cth1 specifically binds within the
30UTR of the SDH4 and ACO1mRNAs in amanner that is depen-
dent on the integrity of the AREs and the TZF RNA-binding
domain.
Expression of Cth2 decreases the half-life of SDH4 mRNA
from 14 to 7 min in cells grown in low Fe (Puig et al., 2005).
To ascertain whether Cth1 also stimulates the turnover of
SDH4 mRNA, SDH4 was conditionally expressed using the
galactose-inducible and glucose-repressible GAL1 promoter in
cth1Dcth2Dsdh4D yeast cells and coexpressed with either the
CTH2:CTH1 plasmid or vector alone (Figure 3D). Cells were
grown in galactose and 100 mMbathophenanthroline disulfonate
(BPS, an Fe-specific chelator) to induce the expression of both
the GAL1-SDH4-30UTR and the CTH2:CTH1 transcription units,
respectively. Transcription of the SDH4 gene was shut off by ad-
dition of glucose, and steady-state mRNA levels were detected
and quantitated over time by RNA blotting. As shown in Fig-
ure 3D, SDH4 mRNA half-life decreased from 15.5 ± 1.6 min to
9.1 ± 1.7 min when Cth1 was expressed. In contrast, there was
no decrease in SDH4 mRNA half-life when the CTH1-C225R
mutant allele was expressed, nor was the SDH4 mRNA half-life
decreased in the presence of wild-type Cth1 when all SDH4
ARE sequences were mutated (SDH4-mt2) (Figure 3D). Taken
together, these data demonstrate that Cth1, like Cth2, can
promote the accelerated turnover of mRNAs in a manner that
is dependent upon a functional Cth1 TZF RNA-binding domain
and ARE sequences within the 30UTR of the target mRNA.
Cth1 Target mRNAs Mostly Encode
Mitochondrial Proteins
In response to Fe-limiting conditions Cth2 promotes the degra-
dation of many mRNAs that encode proteins involved in Fe
homeostasis and Fe-dependent metabolism, thereby mediating
a global remodeling of metabolism that optimizes growth in the
presence of limited available Fe (Puig et al., 2005). Results pre-
sented here (Figure 1) suggest that Cth1 is able to partially com-
pensate for loss of Cth2, suggesting that Cth1 and Cth2 might
play at least partially overlapping roles under conditions of Fe de-
ficiency. The inability of Cth1 to completely rescue cth2D pheno-types could be due to differences in expression levels of both
proteins or to functional differences.
To begin to dissect the individual contributions of Cth1 and
Cth2 in the response to Fe deficiency, we compared the ge-
nome-wide expression patterns of cth1Dcth2D cells expressing
physiological levels of CTH1, CTH2, or vector alone. Figure 4
shows a schematic representation of the results of these exper-
iments from triplicate Affymetrix DNA microarray studies. A total
of 60 mRNAs were downregulated by at least 1.5-fold in the
presence of CTH1. Of the 60 mRNAs downregulated in cells
expressing Cth1, 20 harbor putative 30UTR ARE sequences
(Figure 4; see also Table S1 available online). Among the 20
ARE-containing transcripts that are downregulated by Cth1,
we identified 13 that encode mitochondrial proteins, including
7 proteins involved in respiration, 3 proteins involved in amino
acid biosynthesis, and 3 proteins of uncharacterized function
that are localized tomitochondria. The remaining 7 ARE-contain-
ing transcripts include 2 encoding proteins involved in rRNA
biosynthesis and 5 of diverse function. Downregulation of the re-
maining 40 non-ARE-containing mRNAs in the presence of Cth1
may be an indirect effect of Cth1 function or Cth1 binding to
a noncanonical ARE. It is interesting to note that roughly 25%
of these mRNAs (11 out of 40) encode proteins that have been
identified as localized to themitochondria. These results suggest
that in response to Fe deprivation, Cth1 promotes the preferen-
tial downregulation of mRNAs involved in critical Fe-dependent
mitochondrial processes including respiration and amino acid
biosynthesis.
The microarray results from Cth2-expressing cells confirm our
previous observations (Puig et al., 2005) and increase the num-
ber of mRNAs likely to be direct Cth2 targets (Table S2). A total
of 223 mRNAs were downregulated in Cth2-containing cells un-
der Fe-limiting conditions when compared to cells harboring an
empty vector (Figure 4; Table S2). Ninety-four of these tran-
scripts are potentially direct targets of Cth2, as they harbor either
50-UAUUUAUU-30 or 50-UUAUUUAU-30 ARE consensus se-
quences within their 30UTR. Of the 94 ARE-containing mRNAs,
22 encode proteins involved in respiration, 9 encode proteins
involved in amino acid metabolism, 6 encode proteins involved
in heme/Fe-S cluster biosynthesis, 7 encode proteins involved in
fatty acid metabolism, 6 encode mitochondrial proteins, and
3 encode proteins involved in Fe homeostasis. The remaining
ARE-containing mRNAs encode proteins involved in distinct cel-
lular processes including stress responses, transport, nucleic
acid metabolism, and other processes (Figure 4; Table S2).
Downregulation of the remaining 129 non-ARE-containing
mRNAs could be due to secondary effects of Cth2 activity or
Cth2 binding to nonconsensus AREs. Taken together, these
mRNA expression data indicate that 13 of the 20 target mRNAs
of Cth1 are contained within the set of mRNAs targeted by Cth2
(Figure 4; Table S3). Interestingly, this overlapping subset of 13
ARE-containing mRNAs downregulated by both Cth1 and Cth2
primarily encode proteins involved inmitochondrial functions, in-
cluding oxidative phosphorylation and amino acid biosynthesis.
Cth1/Cth2-Dependent Changes
in Carbohydrate Metabolism
As a facultative anaerobe, S. cerevisiae generates ATP through
both glycolysis and mitochondrial oxidative phosphorylation.
Cell Metabolism
Metabolic Adaptation to Iron LimitationFigure 4. Cth1 and Cth2 Have Nonidentical mRNA Targets
(Left) Representation of the total number of mRNAs downregulated in cells expressing either Cth1 or Cth2, as well as the functional categories of their encoded
proteins. mRNAs corresponding to 223 genes were downregulated by at least 1.5-fold in Cth2-expressing cells, and a total of 60 mRNAs were downregulated in
Cth1-expressing cells. The overlap shows that mRNAs from 16 genes exhibited lower steady-state levels in both Cth1- and Cth2-expressing cells. The overlap-
ping genes primarily encode mitochondrial proteins involved in respiration and amino acid biosynthesis.
(Right) Representation of the subset of ARE-bearing mRNAs downregulated in Cth1- and Cth2-expressing cells. Ninety-four mRNAs that showed decreased
expression levels in the presence of Cth2 harbor ARE sequences, as well as 20 of the mRNAs downregulated in Cth1-containing cells. Of the 16 total overlapping
genes, 13 contain 30UTR ARE sequences.Consistent with important roles for Fe in cellular metabolism, 11
of the 13 ARE-containing mRNAs targeted for degradation by
Cth1 and Cth2 are established or proposed to encode proteins
that play key roles in mitochondrial respiration or other pivotal
mitochondrial functions. Based on these results, Fe deprivation
could lead to rapid loss of mitochondrial function via Cth1- and
Cth2-stimulated mRNA degradation. Moreover, we observed
that the steady-state levels of 17 mRNAs in CTH1-expressing
cells and approximately 40 distinct mRNAs in CTH2 wild-type
cells, but not in cth1Dcth2D cells, are elevated in response to
Fe deficiency (Figure 5A; Tables S4 and S5). Among these
mRNAs are those that encode proteins involved in glucose
uptake (HXT5, HXT6, HXT7, medium- and high-affinity glucose
transporters), glycolysis (HXK1, hexokinase), reserve carbo-
hydrate metabolism (GPH1, glycogen phosphorylase; GSY1,
glycogen synthase; PGM2, phosphoglucomutase; SOL4, 6-
phosphogluconolactonase; YMR090W, dTDP-glucose 4,6-
dehydratase), anaerobic metabolism (COX5b, subunit 5b of
cytochrome oxidase expressed anaerobically; ALD3, aldehyde
dehydrogenase), and other functions proposed to be required
for adaptation to low-glucose conditions (Saccharomyces Ge-
nome Database; http://www.yeastgenome.org/). Furthermore,
several of the genes identified as upregulated in these microar-
rays, such as HSP12, are known to be induced by glucose
deprivation. These experiments also identified genes involved
in DNA repair and meiosis (APN1, MMS1, MSC1, REC104,
and SAE3) as well as genes involved in RNA metabolism
(SNR46, SEN1, and PPE1). These regulatory changes, and their
dependency on Cth1 and Cth2, were confirmed by RNA blot-
ting (Figure 5B). Furthermore, this upregulation was dependent
on both Cth1 and Cth2, as it was not observed in a cth1Dcth2D560 Cell Metabolism 7, 555–564, June 2008 ª2008 Elsevier Inc.strain (Figure 5B and data not shown). A similar pattern of
upregulation of mRNAs that function in glucose uptake, glycol-
ysis, and reserve carbohydrate metabolism is also observed
in wild-type cells in response to Fe deprivation or in cells defec-
tive in Fe-S cluster biogenesis (Puig et al., 2005; Hausmann
et al., 2008). Taken together, these results suggest that Cth1/
Cth2-mediated downregulation of Fe-dependent metabolic
pathways might lead to a secondary energy limitation due
to the degradation of mRNAs encoding key mitochondrial
proteins. This may result in the enhanced expression of mRNAs
encoding high-affinity glucose transporters, glycolytic en-
zymes, and factors involved in the metabolism of reserve
carbohydrates.
Iron Deficiency Elicits Changes
in Carbohydrate Metabolism
Our results suggest that S. cerevisiae cells grown under Fe-lim-
iting conditions have elevated levels of mRNAs encoding pro-
teins involved in high-affinity glucose uptake, glycolysis, reserve
carbohydrate metabolism, and anaerobic metabolism, as well as
mRNAs known to be highly expressed in response to low-glu-
cose conditions (Figure 5A). We found that, concomitant with
the increased levels of these mRNAs, the HXT1 mRNA, which
encodes a low-affinity glucose transporter known to be downre-
gulated during glucose limitation (Ozcan and Johnston, 1999),
was downregulated during Fe-starvation conditions (Table S2).
Similarly, RMD5 and VID24 mRNAs, encoding two proteins
required for the ubiquitination and proteasome-dependent
degradation of fructose 1,6-bisphophatase (FBPase) during
high-glucose conditions, were also found to be downregulated
under Fe-starvation conditions (Table S2). Based on these
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Metabolic Adaptation to Iron LimitationFigure 5. Summary of mRNAs Upregulated in Cells Expressing Either Cth1 or Cth2
(A) Forty mRNAs, whose encoded proteins correspond to the indicated functional categories, showed levels increased by at least 1.5-fold in Cth2-expressing
cells, and a total of 17 mRNAs in cells transformed with Cth1 during Fe deficiency when compared to cells harboring an empty vector. The overlap represents
the common mRNAs upregulated between Cth1- and Cth2-expressing cells.
(B) Microarray validation. Wild-type and cth1Dcth2D cells transformed with pRS416, pRS416-CTH1, or pRS416-CTH2 were grown in medium containing either
300 mM FAS (Fe+) or 100 mM BPS (Fe) and analyzed by RNA blotting. FET3 was used as a control for Fe deprivation, and ACT1 was used as a loading control.
(C) Representation of a partial list of genes upregulated in CTH2 wild-type cells in response to Fe deficiency grouped by transcription factors experimentally
demonstrated to regulate their expression including Msn2/4, Sok2, and Rox1.observations, we hypothesized that Fe deprivation might lead to
secondary glucose starvation. Additionally, a recent report
suggests that cells with impaired mitochondrial Fe-S cluster
assembly and export systems have increased levels of mRNAs
encoding proteins involved in glucose transport (Hausmann
et al., 2008).
The serine/threonine protein kinase Snf1 is a member of the
AMP-activated protein kinase family required for adaptation to
glucose starvation in yeast. During glucose limitation, Snf1 is
phosphorylated, thereby becoming activated and promoting
the upregulation of high-affinity glucose transport systems,
increased glycolysis, and glycogen biosynthesis, among other
activities (Celenza and Carlson, 1986; Wilson et al., 1996;
Hardie et al., 1998). We ascertained the phosphorylation status
of Snf1 kinase in response to Fe deprivation by immunoblot-
ting using antibodies that specifically recognize the phosphor-
ylated form of Snf1. This experiment revealed that Snf1 from
cells grown under Fe-limited but glucose-replete conditions
was more highly phosphorylated than Snf1 from cells grown
under Fe-supplemented conditions (Figure 6A). This suggests
that Fe limitation could lead to a secondary glucose deficiency,
which in turn triggers the phosphorylation-mediated activation
of Snf1 kinase. To examine whether Fe-deficiency-stimulatedSnf1 phosphorylation correlates with changes in cellular car-
bohydrate metabolism and whether this response is depen-
dent on Cth1 and Cth2, we analyzed glycogen content in
wild-type and cth1Dcth2D cells under Fe-sufficient and Fe-de-
pleted conditions. As shown in Figure 6B, cth1Dcth2D cells
and the same mutant harboring wild-type CTH1 and CTH2
genes, grown under Fe-supplemented conditions, accumulate
similar levels of glycogen. In contrast, under Fe-deficient con-
ditions, cells containing the wild-type CTH1 and CTH2 genes
accumulate approximately 7-fold higher levels of glycogen
when compared to isogenic cth1Dcth2D cells. These results
suggest that during Fe deficiency, wild-type cells both activate
Snf1 kinase and hyperaccumulate glycogen, and this hyperac-
cumulation is dependent on the presence of Cth1 and Cth2
activity.
DISCUSSION
Fe functions as a cofactor for a broad range of enzymes that are
essential for normal growth, maintenance, and development,
and organismsmust continually adapt to changes in Fe availabil-
ity. Previous studies have identified regulatory mechanisms in
response to Fe availability at the level of gene transcription,Cell Metabolism 7, 555–564, June 2008 ª2008 Elsevier Inc. 561
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Metabolic Adaptation to Iron LimitationmRNA stability, translation, protein degradation, and protein
trafficking (Escolar et al., 1999; Moseley et al., 2002; Hentze
et al., 2004; Lee et al., 2005; Kaplan et al., 2006; Rouault,
2006; Philpott and Protchenko, 2008). Under conditions of Fe
scarcity, S. cerevisiae cells induce the expression of the Cth2
mRNA-binding protein, which stimulates the turnover of many
mRNAs encoding proteins that function in Fe homeostasis, Fe
storage, and Fe-dependent metabolism. While cth2D cells
exhibit a growth defect under conditions of Fe starvation and
defective target mRNA turnover, the additional deletion of the
CTH1 gene, encoding a homologous RNA-binding protein, exac-
erbates these defects.
Observations reported here support a specific role for CTH1
during Fe deficiency and include the Aft1/2-dependent activa-
tion of the CTH1 promoter in response to Fe deficiency. In addi-
tion, a FLAG-Cth1 fusion protein was expressed rapidly, but
transiently, after cells were deprived of Fe. Preliminary observa-
tions suggest that Cth2 can bind to and promote the destabiliza-
tion of the CTH1 transcript (unpublished data). While this mech-
anism has not been explored, it could at least in part account for
the decreased steady-state levels of the Cth1 protein after 2 hr
of Fe chelation (Figure 3E; unpublished data) and suggests
tight regulatory mechanisms for Cth1 expression during Fe defi-
ciency. Furthermore, this rapid but transient expression of Cth1
would explain why previous experiments, using prolonged
Fe-deficient growth conditions, did not identify CTH1 as an
Figure 6. Iron Deficiency Elicits Changes in Carbohydrate
Metabolism
(A) Fe deficiency-dependent phosphorylation of Snf1. Snf1-3HA was immuno-
precipitated from cells grown in 300 mM FAS (Fe+) or 100 mM BPS (Fe).
Immunoprecipitates were analyzed by immunoblotting using anti-Snf1 and
phosphospecific anti-Snf1 antibodies. As negative and positive controls for
Snf1-3HA phosphorylation, cells were also grown on 4% or 0.05% glucose
(Glc) medium, respectively.
(B) Fe deficiency-induced glycogen hyperaccumulation. Cells were grown in
the presence of 300 mM FAS (Fe+) or 100 mM BPS (Fe), and total glycogen
content was analyzed as described by Parrou and Franc¸ois (1997). Error
bars represent standard deviation.562 Cell Metabolism 7, 555–564, June 2008 ª2008 Elsevier Inc.Fe-responsive gene (Rutherford et al., 2003; Shakoury-Elizeh
et al., 2004; Puig et al., 2005).
While at present we cannot eliminate the possibility that Cth1
and Cth2 play roles outside of Fe homeostasis, we propose
that a primary function for these two proteins may be to allow
rheostatic adaptation to changes in Fe availability. Small fluctua-
tions inCth1 levels could be sufficient for adaptation tomodest or
transient Fe deficiency by first targeting mitochondrial functions.
If the Fe deficiency is more severe or sustained, Cth2 is strongly
induced and provides a means for more widespread metabolic
changes that, together,would lead toa shift away frommitochon-
drial oxidative phosphorylation and toward thedownregulation of
Fe storage and other Fe-dependent metabolic activities. Further
experiments are required to rigorously test this hypothesis.
While both Cth1 and Cth2 are transcriptionally induced by
Aft1/2, bind ARE mRNA sequences to stimulate mRNA turnover,
and contribute to growth under conditions of Fe deficiency, our
results strongly suggest that these proteins have only partial
functional overlap in the response to Fe deficiency. Analysis of
the mRNA expression pattern of cth1Dcth2D cells expressing
physiological levels of either CTH1 or CTH2 indicates that Cth1
and Cth2 share a subset of mRNA targets. Only 13 common
mRNAs with recognizable AREs are downregulated in cells ex-
pressing either Cth1 or Cth2. These targets common to both
Cth1 and Cth2 include mRNAs encoding proteins involved in mi-
tochondrial respiration and mitochondria-localized amino acid
metabolism (Table S3). It is currently unclear what determinants
give rise to distinct mRNA target specificity for these two similar
RNA-binding proteins.
Given the critical role that Fe plays in mitochondrial oxidative
phosphorylation, the results presented here suggest an ad-
ditional important role for Cth1 and Cth2 in facilitating a transi-
tion between oxidative phosphorylation and glycolytic metabo-
lism in response to Fe deficiency. Wild-type cells, but not
cth1Dcth2D cells, accumulate transcripts encoding proteins
involved in glucose uptake, glycolysis, and reserve carbohydrate
metabolism in concert with the downregulation of those encod-
ing proteins essential for mitochondrial oxidative phosphoryla-
tion and other critical mitochondrial processes. To begin to un-
derstand the nature of this coordinate upregulation of these
mRNAs, their cognate genes were grouped according to their
validated regulation by gene-specific transcription factors. As
shown in Figure 5C, of the genes annotated in the YEASTRACT
database (http://www.yeastract.com/) (36 of 40), 50% are acti-
vated by the Msn2/4 stress-responsive transcription factors,
40% are activated by Sok2, and 36% are activated by Rox1.
Notably, Msn2 and Msn4 are known induce gene expression
in response to glucose deprivation, Sok2 responds to cAMP
levels, and Rox1 is a heme-dependent repressor of hypoxic
genes. Currently, there is no evidence supporting the notion
that proteins belonging to the Cth family can stabilize mRNAs.
As such, we hypothesize that Fe deficiency that leads to
Cth1/Cth2-dependent mitochondrial inactivation, through their
mRNA-destabilizing activity, would activate each of the signal-
ing pathways that regulate the Msn2/4, Sok2, and Rox1 tran-
scription factors, thus promoting an elevation in the steady-
state levels of the mRNAs encoding proteins involved in glucose
metabolism (Ward et al., 1995; Lowry and Zitomer, 1984; Ter
Linde and Steensma, 2002).
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Yeast Strains and Growth Conditions
The AFT1-TAP strain was obtained from the TAP-tag collection (Ghaemma-
ghami et al., 2003) and verified by PCR and immunoblotting. The snf1D strain
used was DTY434 (Mata ade2-101 trp1D1 lys2-801 ura3-52 snf1D). All other
yeast strains used in this study have been described previously (Puig et al.,
2005). For spot assays, cells were grown in synthetic complete medium (SC)
minus specified nutrients tomidexponential phase and spotted in 10-fold serial
dilutions starting at A600 = 0.1 on SC or SC plus 750 mM of the membrane-per-
meableFechelator ferrozine to imposeFestarvation. For liquidcultures, 100mM
of the Fe-specific chelator bathophenanthroline disulfonate (BPS) was used to
imposeFe deficiency, and 300 mMferrous ammoniumsulfate (FAS)was used to
create Fe-replete conditions (cultures grown under these conditions for 6–8 hr
reachanOD600=0.4–0.6). Thus, all conditionsdescribedasFe andFe+ refer
to supplementation of either BPS or FAS in liquid cultures. Yeast three-hybrid
experiments were carried out as described previously (Puig et al., 2005).
Plasmids
The overlap extension method was used to create the CTH2:CTH1 fusion and
to create gene, promoter, and 30UTR mutations. The coding sequences from
wild-type CTH2 and CTH1 were cloned into the p416TEF vector using stan-
dard cloning methods. Wild-type CTH1 and CTH1-C225R alleles were fused
to the Gal4 activation domain in the pACT2 vector and used for the yeast
three-hybrid assay. Other plasmids used in this work have been described pre-
viously (Puig et al., 2005). Both the 23FLAG-CTH1 and the CTH2 genes were
under the regulation of their endogenous promoter and 30UTRs. All plasmid
inserts were verified by sequencing. Plasmid pSNF1-316 was a gift from
M. Schmidt (University of Pittsburgh).
Chromatin Immunoprecipitation
Overnight cultures of AFT1-TAP cells (Ghaemmaghami et al., 2003) were rein-
oculated to A600 = 0.1 in 50 ml SC supplemented with either 300 mM FAS (Fe+)
or 100 mM BPS (Fe) and grown for 8 hr at 30C. Formaldehyde crosslinking
andChIP using 500 mg of total protein were carried out as described previously
(Keller et al., 2005) in three independent experiments. Promoter occupancy by
Aft1 was ascertained by PCR using primers annealing at the promoter region of
CTH1. Primers for FET3 and CTH2 promoters were used as positive controls,
and CMD1 was used as a negative control. PCR products were visualized on
2% agarose gels using ethidium bromide.
mRNA Half-Life Determination
Cells were grown overnight in SC-Ura-Leu-raffinose (2% raffinose, no glucose)
and reinoculated in SC-Ura-Leu-galactose (2%galactose, no glucose) supple-
mented with 100 mM BPS until exponential growth phase (OD600 = 0.4–0.6).
Glucosewas added to a final concentration of 4% to extinguish transcription of
the GAL1-SDH4 fusions. Aliquots were taken after glucose addition, and total
RNA was extracted and analyzed by RNA blotting using SDH4 and ACT1
probes. SDH4 levels were quantified using a STORM 840 PhosphorImager
(Amersham) and normalized to ACT1 levels. The mRNA half-life was deter-
mined from at least three independent experiments.
Protein Analyses
cth1Dcth2D cells were cotransformed with pRS415-CTH2 and pRS416-
23FLAG-CTH1. Overnight cultures were reinoculated to OD600 = 0.05 in SC-
Ura-Leu and allowed to grow to OD600 = 0.1. Once cultures reached OD600 =
0.1, BPS was added to a final concentration of 100 mM, and aliquots were col-
lected at 0, 0.5, 1, 2, 3, 4, and 5 hr following addition of BPS. Total protein was
extracted using the Triton X-100/glass beadmethod, and 50 mg of total protein
was resolved in a 10% SDS-PAGE gel and transferred onto a nitrocellulose
membrane. FLAG-Cth1 fusion protein was detected using an HRP-conjugated
a-FLAG antibody (Sigma). a-Pgk1 antibody was used as a loading control. The
chemiluminescence substrates Pico and Fempto (Pierce) were used for detec-
tion of theHRP-conjugated antibody. To detect Snf1 phosphorylation, DTY434
cells (snf1D) were transformed with plasmid pSNF1-316 (SNF1-3HA) or vector
alone and grown in SC-Ura overnight. Overnight cultures were reinoculated to
A600 = 0.2 in SC-Ura supplemented with either 300 mMFAS or 100 mMBPS and
grown for 6 hr at 30C. Protein extractions were performed using ice-cold RIPAbuffer and glass beads supplemented with protease inhibitors (Rocheminitab-
let) and phosphatase inhibitors (30 mMNa4P207, 50 mMNaF, 100 mMNa3VO4,
25mMb-glycerophosphate). Total protein (500mg)wasused to immunoprecip-
itate Snf1-3HA with 20 ml of monoclonal anti-HA agarose conjugate beads
(Sigma) using a standard IP protocol. Immunoprecipitated samples were frac-
tionated in 10% SDS-PAGE gels and transferred onto nitrocellulose mem-
branes, andphosphospecific antibodies against Snf1 (anti-PT210 [M. Schmidt,
University of Pittsburgh] or anti-P-AMPKa [Cell Signaling]) as well as anti-Snf1
(yK-16, Santa Cruz) as loading control were used. For positive and negative
controls of Snf1 phosphorylation, additional cultures were grown in SC-Ura
containing either 4% or 0.05% glucose, respectively.
Microarray Analyses
cth1Dcth2D cells independently transformed with pRS416, pRS416-CTH1, or
pRS416-CTH2 were grown in triplicate in SC-Ura containing 100 mMBPS until
exponential growth phase, and RNA was extracted, labeled, and hybridized to
Affymetrix Yeast Genome S98 arrays. (For further information about sample
preparation, synthesis of labeled cDNA, hybridization, scanning and data
acquisition, and quality control steps, visit the Duke Microarray Core Facility
at http://www.genome.duke.edu/cores/microarray/.) All data were analyzed
using GeneSpring 6.1 (Silicon Genetics), using volcano plot with minimum of
1.5-fold change and a p value < 0.05.
Glycogen Measurements
cth1Dcth2D mutants were transformed with vectors (pRS416 + pRS415) or
with both CTH plasmids (pRS416-CTH1 + pRS415-CTH2), inoculated at
OD600 = 0.1 in SC-Ura-Leu, and grown for 8 hr in medium containing either
300 mM FAS or 100 mM BPS. Glycogen extraction and determination were
performed as described in Parrou and Franc¸ois (1997).
ACCESSION NUMBERS
Microarray data have been deposited in the NCBI Gene Expression Omnibus
(http://www.ncbi.nlm.nih.gov/geo/) and are accessible through GEO Series
accession number GSE11236.
SUPPLEMENTAL DATA
Supplemental Data include five tables and can be found with this article online
at http://www.cellmetabolism.org/cgi/content/full/7/6/555/DC1/.
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